Anke L W Huckriede (Anke Huckriede)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 12

Top Topics

Molecularly Imprinted

Gestational Age

Immune Response

High Fat Diet Induced

Top Venues

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Renée S van der Kooij, Martin Beukema, Anke L W Huckriede, Johan Zuidema, Rob Steendam, Henderik W Frijlink, Wouter L J Hinrichs
A Single Injection with Sustained-Release Microspheres and a Prime-Boost Injection of Bovine Serum Albumin Elicit the Same IgG Antibody Response in Mice. Pharmaceutics 15 (2) (2023)
Renée S van der Kooij, Martin Beukema, Anke L W Huckriede, Johan Zuidema, Rob Steendam, Henderik W Frijlink, Wouter L J Hinrichs
A Single Injection with Sustained-Release Microspheres and a Prime-Boost Injection of Bovine Serum Albumin Elicit the Same IgG Antibody Response in Mice. Pharmaceutics 15 (2) (2023)
Renée S van der Kooij, Martin Beukema, Anke L W Huckriede, Johan Zuidema, Rob Steendam, Henderik W Frijlink, Wouter L J Hinrichs
A Single Injection with Sustained-Release Microspheres and a Prime-Boost Injection of Bovine Serum Albumin Elicit the Same IgG Antibody Response in Mice. Pharmaceutics 15 (2) (2023)
Rick Heida, Paul Hagedoorn, Melle C van Meel, Jurrie E R Prins, Frederike S Simonis, Renate Akkerman, Anke L W Huckriede, Henderik W Frijlink, Anne H de Boer, Wouter L J Hinrichs
Performance Testing of a Homemade Aerosol Generator for Pulmonary Administration of Dry Powder Formulations to Mice. Pharmaceutics 15 (7) (2023)
Shuran Gong, Putri Fajar, Jacqueline De Vries-Idema, Anke L W Huckriede
Comparison of media for a human peripheral blood mononuclear cell-based in vitro vaccine evaluation system. Clinical and experimental vaccine research 12 (4) (2023)
Rick Heida, Philip A Born, Gabriela Tapia-Calle, Henderik W Frijlink, Anna Salvati, Anke L W Huckriede, Wouter L J Hinrichs
Assessing the Immunomodulatory Effect of Size on the Uptake and Immunogenicity of Influenza- and Hepatitis B Subunit Vaccines In Vitro. Pharmaceuticals (Basel, Switzerland) 15 (7) (2022)
Marilena Paola Etna, Aurora Signorazzi, Daniela Ricci, Martina Severa, Fabiana Rizzo, Elena Giacomini, Andrea Gaggioli, Isabelle Bekeredjian-Ding, Anke L W Huckriede, Eliana Marina Coccia
Human plasmacytoid dendritic cells at the crossroad of type I interferon-regulated B cell differentiation and antiviral response to tick-borne encephalitis virus. PLoS pathogens 17 (4) (2021)
Aurora Signorazzi, Jeroen L A Pennings, Marilena P Etna, Malou Noya, Eliana Marina Coccia, Anke L W Huckriede
In Vitro Characterization of the Innate Immune Pathways Engaged by Live and Inactivated Tick-Borne Encephalitis Virus. Vaccines 9 (6) (2021)
Yu Tian, Yoshita C Bhide, Herman J Woerdenbag, Anke L W Huckriede, Henderik W Frijlink, Wouter L J Hinrichs, J Carolina Visser
Development of an Orodispersible Film Containing Stabilized Influenza Vaccine. Pharmaceutics 12 (3) (2020)
Yoshita Bhide, Wei Dong, Tjarko Meijerhof, Jacqueline de Vries-Idema, Hubert G Niesters, Anke L W Huckriede
Characterization of humoral immune responses and degree of protection induced by influenza vaccine in cotton rats: Effects of low vaccine dose and single vs booster vaccination. Immunity, inflammation and disease 8 (3) (2020)
Gabriela Tapia-Calle, Philip A Born, Georgia Koutsoumpli, Martin Ignacio Gonzalez-Rodriguez, Wouter L J Hinrichs, Anke L W Huckriede
A PBMC-Based System to Assess Human T Cell Responses to Influenza Vaccine Candidates In Vitro. Vaccines 7 (4) (2019)
Wei Dong, Yoshita Bhide, Sonny Marsman, Marijke Holtrop, Tjarko Meijerhof, Jacqueline de Vries-Idema, Aalzen de Haan, Anke L W Huckriede
Monophosphoryl Lipid A-Adjuvanted Virosomes with Ni-Chelating Lipids for Attachment of Conserved Viral Proteins as Cross-Protective Influenza Vaccine. Biotechnology journal 13 (4) (2018)